Conquering Diseases

Study Of An Investigational Immune Modulator For Covid-19 In Hospitalized Adults

Description

Seeking men and women who have been hospitalized for moderate to severe COVID-19 for a study to evaluate whether adding one of several different immune modulators to standard care with remdesivir improves recovery from illness.

Overview

All participants in this study will be treated with remdesivir. Participants will also be randomly assigned to get one of several different investigational immune modulator drugs or placebo (looks like the investigational drug but contains no medicine).

What we're hoping for

We hope to evaluate whether adding an investigational immune modulator to treatment with remdesivir for moderate to severe COVID-19 in hospitalized adults improves the time to recovery.

Additional Information

ClinicalTrials.gov Identifier: NCT04593940

 Principal Investigator

Robert  Finberg, MD

University of Massachusetts Medical School

 Study Contact

Shestruma  Parajuli

shestruma.parajuli@umassmed.edu

 Location

UMMS University Campus

55 Lake Ave North 

Worcester,MA 01655

508-856-8989